<code id='9019422046'></code><style id='9019422046'></style>
    • <acronym id='9019422046'></acronym>
      <center id='9019422046'><center id='9019422046'><tfoot id='9019422046'></tfoot></center><abbr id='9019422046'><dir id='9019422046'><tfoot id='9019422046'></tfoot><noframes id='9019422046'>

    • <optgroup id='9019422046'><strike id='9019422046'><sup id='9019422046'></sup></strike><code id='9019422046'></code></optgroup>
        1. <b id='9019422046'><label id='9019422046'><select id='9019422046'><dt id='9019422046'><span id='9019422046'></span></dt></select></label></b><u id='9019422046'></u>
          <i id='9019422046'><strike id='9019422046'><tt id='9019422046'><pre id='9019422046'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:3423
          1:43Traders work on the floor of the New York Stock Exchange on July 12, 2023 in New York City.Spencer Platt/Getty Images

          As long-standing recession alarms continue to blare from some forecasters, investors don’t appear to hear them.

          The S&P 500 this year, when excluding the ten largest companies, stands at single-digit gains.

          Looking ahead, Agati and Moya said they expect the stock market to decline over the remainder of the year, ending 2023 with positive but modest returns. The full economic cooling-off effects of central bank rate hikes have yet to take hold, they said, adding that inflation may not return to normal levels as soon as investors hope.

          "The rally will stall out here," Moya said.

          MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

          Stoltzfus, however, said there's a "good chance" the stock market will end the year higher than it currently stands.

          "We have maintained a fairly bullish posture," he said. "Where the market is trading right now would suggest to us that it has further to go this year."

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Medicare explains how it will choose drugs for negotiation
          Medicare explains how it will choose drugs for negotiation

          Medicarelaidoutinthegreatestdetailyethowitwillchoosewhichdrugpricesitwillnegotiateinitsbrand-newprog

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Headspace, Meta partner to launch VR meditation app for Quest

          HeadspaceXR,developedwithfundingfromMeta,guidesusersthroughmeditationandotheractivities,suchasaTaiCh